Shanghai Pharmaceuticals Holdings ADR (SHPMY): prezzo delle azioni e notizie

Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets. Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list. Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia

Informazioni su Shanghai Pharmaceuticals Holdings ADR

CEO-

Dipendenti49,6K

Data di fondazione18 gen 1994

Sede-

Settore-

Sito webpharm-sh.com.cn

Tutti i valori in CNY	giu 2025	set 2025	dic 2025	mar 2026
Fatturato	70,83 Mld	73,48 Mld	68,51 Mld	75,26 Mld
Costo dei beni venduti	63,12 Mld	66,03 Mld	60,55 Mld	67,17 Mld
Costo del venduto	63,12 Mld	66,03 Mld	60,55 Mld	67,17 Mld
Spese di ricerca e sviluppo	461,93 Mln	556,53 Mln	824,53 Mln	468,22 Mln
Spese totali per ricerca e sviluppo	-	-	-	-
Spese di vendita, generali e amministrative	4,70 Mld	4,70 Mld	4,97 Mld	4,59 Mld
Spese operative	5,44 Mld	5,58 Mld	5,91 Mld	5,47 Mld
Spese operative totali	68,56 Mld	71,60 Mld	66,47 Mld	72,63 Mld
Reddito operativo	2,27 Mld	1,88 Mld	2,04 Mld	2,63 Mld
Altri redditi non operativi	-5,42 Mln	-84,84 Mln	-63,65 Mln	-47,88 Mln
EBT inclusi elementi straordinari	4,67 Mld	1,48 Mld	1,52 Mld	2,42 Mld
EBT esclusi elementi straordinari	4,99 Mld	1,61 Mld	1,44 Mld	2,27 Mld
Spese per imposte sul reddito	1,31 Mld	485,91 Mln	534,14 Mln	569,09 Mln
Aliquota fiscale effettiva	28,14%	32,89%	35,10%	23,52%
Altre spese operative	100,05 Mln	129,62 Mln	271,29 Mln	132,16 Mln
Risultato netto	3,13 Mld	688,20 Mln	577,49 Mln	1,42 Mld
Margine di profitto netto	4,41%	0,94%	0,84%	1,88%
Utili per azione	-	-	-	-
Interessi e reddito da investimento	3,18 Mld	206,57 Mln	-	38,70 Mln
Interesse passivo	-443,61 Mln	-393,02 Mln	-470,36 Mln	-347,64 Mln
Interessi passivi netti	2,73 Mld	-186,45 Mln	-470,36 Mln	-308,94 Mln
Addebiti per ammortamento e svalutazione	-	-	-	-
EBITDA	2,74 Mld	2,26 Mld	2,54 Mld	3,12 Mld
Utile o perdita derivante dalla vendita di asset	-39,99 Mln	39,99 Mln	-157,15 Mln	-

I contenuti creati con l'AI potrebbero contenere errori. Scopri di più

AssistenzaInvia feedbackPrivacy Termini Disclaimer

Google Finanza

Ricerca